Inventor · disambiguated record
Virginia M.Y. Lee
Also filed as: LEE VIRGINIA M · LEE VIRGINIA M-Y
19 granted patents·15 pending applications·202 citations·filing 1993–2024
93Inventor score
Top patents by PatentIndex Score
34 records- 0183US11155608B2Monoclonal antibodies against pathological alpha-synuclein, and methods using sameUNIV PENNSYLVANIA·Filed 2018·Granted Oct 26, 2021·2 cites·18 claims
- 0281US2025136670A1Monoclonal Antibodies Against Alpha-Synuclein FibrilsUNIV PENNSYLVANIA·Filed 2024·Application pending·0 cites
- 0380US9649317B2Heterocyclic compounds and their use for the treatment of neurodegenerative tauopathiesUNIV PENNSYLVANIA·Filed 2013·Granted May 16, 2017·2 cites·32 claims
- 0479US5601985AMethod of detecting abnormally phosphorylated tau(τ)UNIV PENNSYLVANIA·Filed 1995·Granted Feb 11, 1997·44 cites·4 claims
- 0578US5733734AMethod of screening for Alzheimer's disease or disease associated with the accumulation of paired helical filamentsUNIV PENNSYLVANIA·Filed 1993·Granted Mar 31, 1998·37 cites·14 claims
- 0674US12071474B2Monoclonal antibodies against alpha-synuclein fibrilsUNIV PENNSYLVANIA·Filed 2022·Granted Aug 27, 2024·0 cites·7 claims
- 0772US6214334B1Compositions and methods for producing and using homogenous neuronal cell transplants to treat neurodegenerative disorders and brain and spinal cord injuriesUNIV PENNSYLVANIA·Filed 1999·Granted Apr 10, 2001·29 cites·6 claims
- 0871US6358681B2Diagnostic methods for alzheimer's disease by detection of multiple mRNAsUNIV PENNSYLVANIA·Filed 1998·Granted Mar 19, 2002·38 cites·2 claims
- 0966US2022041698A1Monoclonal Antibodies Against Pathological Alpha-Synuclein, and Methods Using SameUNIV PENNSYLVANIA·Filed 2021·Application pending·0 cites
- 1065US11220538B2Monoclonal antibodies against alpha-synuclein fibrilsUNIV PENNSYLVANIA·Filed 2018·Granted Jan 11, 2022·0 cites·23 claims
- 1164US5580898AMethod of stabilizing microtubulesUNIV PENNSYLVANIA·Filed 1994·Granted Dec 3, 1996·23 cites·2 claims
- 1261US7011827B2Compositions and methods for producing and using homogenous neuronal cell transplantsUNIV PENNSYLVANIA·Filed 2001·Granted Mar 14, 2006·5 cites·1 claims
- 1361US5792900ACompositions and methods for producing and using homogenous neuronal cell transplantsUNIV PENNSYLVANIA·Filed 1994·Granted Aug 11, 1998·19 cites·11 claims
- 1460US9643919B2Cycloalkyl-dione derivatives and methods of their useUNIV PENNSYLVANIA·Filed 2014·Granted May 9, 2017·0 cites·30 claims
- 1560US8354236B2Detection of neurodegenerative diseaseUNIV PENNSYLVANIA·Filed 2009·Granted Jan 15, 2013·0 cites·6 claims
- 1658USRE44354EAmyloid plaque aggregation inhibitors and diagnostic imaging agentsKUNG HANK F·Filed 2012·Granted Jul 9, 2013·0 cites·16 claims
- 1756US2023235034A1Monoclonal antibodies against pathological tau, and methods using sameUNIV PENNSYLVANIA·Filed 2021·Application pending·0 cites
- 1855US8927586B2Thromboxane A2 (TP) receptor antagonistsUNIV PENNSYLVANIA·Filed 2013·Granted Jan 6, 2015·0 cites·2 claims
- 1955US2013184441A1Detection of Neurodegenerative DiseaseUNIV PENNSYLVANIA·Filed 2012·Application pending·0 cites
- 2054US7378111B2Regulation of GSK-3α activity for the treatment or prevention of Alzheimer's diseaseUNIV PENNSYLVANIA·Filed 2003·Granted May 27, 2008·1 cites·7 claims
- 2154US2002102594A1Diagnostic methods for Alzheimer's disease by detection of multiple mRNAsFiled 2002·Application pending·0 cites
- 2253US2017173016A1Heterocyclic compounds and their use for the treatment of neurodegenerative tauopathiesUNIV PENNSYLVANIA·Filed 2017·Application pending·0 cites
- 2353US2023167121A1Substituted {1,2,4,} triazolo{1,5-a} pyrimidine compounds and use in stabilizing microtubulesUNIV PENNSYLVANIA·Filed 2021·Application pending·0 cites
- 2451US11623927B2Substituted [1,2,4]triazolo[1,5-a]pyrimidines for stabilizing microtubulesUNIV PENNSYLVANIA·Filed 2019·Granted Apr 11, 2023·0 cites·18 claims
- 2551US2006029575A1Compositions and methods for producing and using homogenous neuronal cell transplantsLEE VIRGINIA M·Filed 2005·Application pending·0 cites
- 2650US2013190370A1Novel Tetrahydronaphalene Antagonists to the Thromboxane A2 (TP) ReceptorTROJANOWSKI JOHN Q·Filed 2011·Application pending·0 cites
- 2749US2023025707A1Anti-Alpha-Synuclein Monoclonal Antibodies, and Methods Using SameUNIV PENNSYLVANIA·Filed 2020·Application pending·0 cites
- 2848US2010068308A1Regulation of GSK-3alpha activity for the treatment or prevention of Alzheimer's diseaseUNIV PENNSYLVANIA·Filed 2008·Application pending·0 cites
- 2946US2013251731A1Tau Acetylation in the Pathogenesis of Alzheimers Disease and Other Related TauopathiesUNIV PENNSYLVANIA·Filed 2013·Application pending·0 cites
- 3039US2013337463A1Cell-Based Models of Neurodegenerative DiseaseBRUNDEN KURT R·Filed 2011·Application pending·0 cites
- 3139US2003217370A1Transgenic animal expressing alpha-synuclein and uses thereofFiled 2002·Application pending·0 cites
- 3238US2013029983A1Aminothienopyridazine inhibitors of tau assemblyBALLATORE CARLO·Filed 2010·Application pending·0 cites
- 3331US8530520B2Cycloalkyl-dione derivatives and methods of their useATASOYLU ONUR·Filed 2012·Granted Sep 10, 2013·0 cites·28 claims
- 3430US5849988ARat comprising straight filaments in its brainUNIV PENNSYLVANIA·Filed 1994·Granted Dec 15, 1998·2 cites·28 claims
Join the waitlist — get patent alerts
Get an alert when Virginia M.Y. Lee files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →